ENTITY

Deshengtang Pharmaceutical Co Ltd (DESE HK)

1
Analysis
Health CareHong Kong

26 Jun 2023 08:55

Pre-IPO Deshengtang Pharmaceutical - Benign Development Momentum, but Still Face Some Risks

Deshengtang has hope for an early turnaround if benign development momentum could continue. But its business model does not have a high moat, so...

Logo
289 Views
Share
No more insights
x